Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Capecitabine
Peritoneal Cancer
Sun Yat-sen University
P2/3
B
(60)
Capecitabine
Peritoneal Neoplasms
Sun Yat-sen University
P2/3
B
(60)
Cediranib
Fallopian Tube Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(60)
Cimetidine
Breast Cancer
Ohio State University Comprehensive Cancer Center
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Glioblastoma
Sichuan Honghe Biotechnology Co., Ltd.
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Gliosarcoma
National Cancer Institute (NCI)
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Portal Vein Thrombosis
Shandong Cancer Hospital and Institute
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
T-cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P2/3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
T Lymphoblastic Lymphoma
Children's Oncology Group
P2/3
B
(60)
Cnm-Au8
Amyotrophic Lateral Sclerosis
Clene Nanomedicine
P2/3
B
(60)
Crisugabalin
Diabetic Neuropathy
Haisco Pharmaceutical Group Co., Ltd.
P2/3
B
(60)
Dabrafenib
Skin Carcinoma
Cancer Research UK
P2/3
B
(60)
DARATUMUMAB
T-Lymphoblastic Lymphoma
Children's Oncology Group
P2/3
B
(60)
Dasatinib
CD19+ Acute Leukemia
SWOG Cancer Research Network
P2/3
B
(60)
Decitabine
Conditioning
Nanfang Hospital, Southern Medical University
P2/3
B
(60)
DEXKETOPROFEN
Hemorrhagic Stroke
Beijing Tiantan Hospital
P2/3
B
(60)
DEXTROSE
Pain, Chronic
National and Kapodistrian University of Athens
P2/3
B
(60)
dnl343
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD
P2/3
B
(60)
D-thioctic acid
Diabetic Peripheral Neuropathic Pain
Haisco Pharmaceutical Group Co., Ltd.
P2/3
B
(60)
Esomeprazole
Helicobacter Pylori Infection
Sohag University
P2/3
B
(60)
FILGRASTIM
Conditioning
First Affiliated Hospital Xi'an Jiaotong University
P2/3
B
(60)
Finotonlimab
Hepatocellular Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
P2/3
B
(60)
FLUOROURACILUM
Lung Cancer
Tango Therapeutics, Inc.
P2/3
B
(60)
Showing 476 to 500 of 1,482 assets
Previous
Page 20 of 60
Next